Secondary Hemophagocytic Lymphohistiocytosis Following Dostarlimab Treatment in a Patient With Metastatic Endometrial Cancer
346 view(s)
0 comment(s)
World Journal of Oncology
Volume 15, Number 5, October 2024, pages 844-850
By Emilie Rollet et al.